CTIC - CTI BioPharma Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 550.3M
Enterprise Value 3-2.51M
Trailing P/E N/A
Forward P/E 1-0.88
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)3.13
Price/Book (mrq)1.00
Enterprise Value/Revenue 3-0.16
Enterprise Value/EBITDA 60.07

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -224.53%
Operating Margin (ttm)-234.03%

Management Effectiveness

Return on Assets (ttm)-24.57%
Return on Equity (ttm)-59.41%

Income Statement

Revenue (ttm)16.08M
Revenue Per Share (ttm)0.28
Quarterly Revenue Growth (yoy)-94.10%
Gross Profit (ttm)25.41M
EBITDA -37.06M
Net Income Avi to Common (ttm)-36.11M
Diluted EPS (ttm)-0.6230
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)62.25M
Total Cash Per Share (mrq)1.07
Total Debt (mrq)19.12M
Total Debt/Equity (mrq)42.87
Current Ratio (mrq)4.04
Book Value Per Share (mrq)0.87

Cash Flow Statement

Operating Cash Flow (ttm)-40.86M
Levered Free Cash Flow (ttm)-26.55M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.30
52-Week Change 3-83.26%
S&P500 52-Week Change 34.96%
52 Week High 35.3600
52 Week Low 30.6000
50-Day Moving Average 30.9611
200-Day Moving Average 31.1483

Share Statistics

Avg Vol (3 month) 3278.98k
Avg Vol (10 day) 3259.5k
Shares Outstanding 557.97M
Float 35.62M
% Held by Insiders 10.76%
% Held by Institutions 161.04%
Shares Short (Apr 30, 2019) 41.69M
Short Ratio (Apr 30, 2019) 47.49
Short % of Float (Apr 30, 2019) 43.46%
Short % of Shares Outstanding (Apr 30, 2019) 42.91%
Shares Short (prior month Mar 29, 2019) 41.39M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jan 3, 2017